1. General Understanding of Disease

Understanding the state of knowledge of pathogenesis of IBD, and the principles underlying treatment


Full content only available after log-in


1.1. Knows the science underlying the pathogenesis of IBD, in particular relating to genetic and environmental factors involved, and differences between ulcerative colitis (UC) , Crohn’s disease (CD) and IBD unclassified

1.2. Understands the natural history of UC and Crohn’s disease, including its variability and the impact of therapy on the natural history

1.3. Understands the importance of communicating with patients and educating them about their disease and its natural history as well as the principals of management

1.4. Understands the basic immunology of IBD and mechanism of action (as far as it is understood) and rationale for using different treatment types in IBD

1.5. Able to use knowledge of modifiable and non-modifiable risk factors to underlie management decisions and to stratify risk for patients


        
 
Topic:





Programme Phase:



Content Format:








Page: () 1 2 3 4 5 6 7 ()

Topic 1.4 : State of the art

JAK-inhibitors

S Vermeire

ECCO 2017 Barcelona Congress

Webcast + PPT
 


Topic 1.4 : State of the art

Anti IL12/IL23 compounds

B Sands

ECCO 2017 Barcelona Congress

Webcast + PPT
 


Topic 1.4 : Educational update

Tissue healing and current biological therapy

G Van den Brink

ECCO 2015 Barcelona Congress

Webcast
 


Topic 1.5 : Educational update

How to communicate risks of disease or treatment with a patient?

P Irving, M Harbord

Talking Heads
 


Topic 1.5 : Educational update

Travelling with IBD

S Vavricka, S Ben-Horin

Talking Heads
 


Topic 1.5 : Educational update

Therapeutic Drug Monitoring

M Ferrante, A Armuzzi, F Magro

Talking Heads
 


Topic 1.5 : Educational update

IBD Drugs in Pregnancy - Current Controversies

J van der Woude, S Kanis

Talking Heads
 


Topic 1.5 : Educational update

Influence of the inflammatory burden on pharmacokinetics of biologicals

D Mould

ECCO 2015 Barcelona Congress

Webcast
 


Topic 1 :

An introduction to pharmacoepidemiology

L. Peyrin-Biroulet

ECCO'18 Vienna

Webcast + PPT
 


Topic 1 :

Can the patient become an investigator?

G. Bianchi

ECCO'18 Vienna

Webcast + PPT
 


Page: () 1 2 3 4 5 6 7 ()